Colorectal Cancer
The following are a selection of key clinical trials that are currently recruiting patients for inclusion in investigations of new therapies or new combinations of available therapies for patients with colorectal cancer. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their eligible patients to one of these clinical trials.
A report on navigating barriers to care and providing the best support for patients with colorectal cancer.
According to a recent assessment of bowel dysfunction–related needs, the hardships for colorectal cancer (CRC) survivors continue long after leaving the operating room, and survivors desire more information and strategies to help cope with unexpected changes to their bowel patterns, researchers said at the 2015 Gastrointestinal Cancers Symposium held in San Francisco, CA.
The following clinical trials are currently recruiting patients with colorectal cancer for inclusion in several investigations.
The number of cancer survivors is estimated at 13.5 million, and the American College of Surgeons (ACoS) requires cancer survivorship care plans that include details regarding patients’ disease and treatments.
- 1
- 2
Page 2 of 2
Results 11 - 16 of 16
Results 11 - 16 of 16
